These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34563128)
1. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials. Kim HS; Sol IS; Li D; Choi M; Choi YJ; Lee KS; Seo JH; Lee YJ; Yang HJ; Kim HH BMC Pulm Med; 2019 Dec; 19(1):251. PubMed ID: 31852460 [TBL] [Abstract][Full Text] [Related]
3. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Wang YS; Zhou YL; Bai GN; Li SX; Xu D; Chen LN; Chen X; Dong XY; Fu HM; Fu Z; Hao CL; Hong JG; Liu EM; Liu HM; Lu XX; Luo ZX; Tang LF; Tian M; Yin Y; Zhang XB; Zhang JH; Zhang HL; Zhao DY; Zhao SY; Zhu GH; Zou YX; Lu Q; Zhang YY; Chen ZM World J Pediatr; 2024 Sep; 20(9):901-914. PubMed ID: 39143259 [TBL] [Abstract][Full Text] [Related]
4. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis. Song X; Zhou N; Lu S; Gu C; Qiao X BMC Infect Dis; 2024 Oct; 24(1):1166. PubMed ID: 39407159 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Macrolide-resistant Mycoplasma pneumoniae Pneumonia in Children: A Meta-analysis of Macrolides Versus Tetracyclines. Bolormaa E; Park JY; Choe YJ; Kang CR; Choe SA; Mylonakis E Pediatr Infect Dis J; 2024 Oct; ():. PubMed ID: 39383346 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Lee H; Yun KW; Lee HJ; Choi EH Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T; PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170 [TBL] [Abstract][Full Text] [Related]
9. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Cao B; Qu JX; Yin YD; Eldere JV Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811 [TBL] [Abstract][Full Text] [Related]
10. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891 [TBL] [Abstract][Full Text] [Related]
11. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867 [TBL] [Abstract][Full Text] [Related]
12. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534 [TBL] [Abstract][Full Text] [Related]
13. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Lung DC; Yip EK; Lam DS; Que TL Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339 [TBL] [Abstract][Full Text] [Related]
14. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure. Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant Choi JH; Seong GM; Ko Y; Kim YR; Kim C Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744 [No Abstract] [Full Text] [Related]
16. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults. Hanada S; Morozumi M; Takahashi Y; Mochizuki S; Sato T; Suzuki S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Ubukata K; Kishi K Intern Med; 2014; 53(15):1675-8. PubMed ID: 25088885 [TBL] [Abstract][Full Text] [Related]
17. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263 [TBL] [Abstract][Full Text] [Related]
18. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455 [TBL] [Abstract][Full Text] [Related]
19. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. Kim K; Jung S; Kim M; Park S; Yang HJ; Lee E JAMA Netw Open; 2022 Jul; 5(7):e2220949. PubMed ID: 35816304 [TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]